Drug used to reduce blood fats might cut SARS-CoV-2 infection by 70% Kumar Jeetendra | August 6, 2021 An oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, according to a lab study published on Friday. The team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active …
WHO calls for ban on COVID-19 vaccine booster dose Kumar Jeetendra | August 4, 2021 The World Health Organization is calling for a moratorium on COVID-19 vaccine boosters until at least the end of September, its head Tedros Adhanom Ghebreyesus said on Wednesday. The move was to enable that at least 10% of the population of every country was vaccinated, Tedros said. “I understand the concern of all governments to …
Minimizing Covid-19 deaths by accelerated vaccination strategies despite limited vaccine supply Kumar Jeetendra | August 3, 2021 Basel, Switzerland – 3rd August 2021 – Life Science Newswire – In the Covid-19 pandemic, new waves of Coronavirus “Variants of Concern” are currently observed in many countries and vaccination is one cornerstone of overcoming the pandemic. While many countries have chosen an “Elderly first, one dosage fits all” approach to vaccination, Swiss scientists have …
Honeywell establishes covid critical care centre in Mumbai Kumar Jeetendra | August 3, 2021 Mumbai, August 3, 2021 – Honeywell today announced that it has established an intensive care unit (ICU) facility at the Dahisar COVID-19 Jumbo Centre in the city to treat critical COVID-19 patients. This is the second such facility set up as part of Honeywell’s COVID relief efforts in the country. The company established a similar …
Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
Scientists test a library of lipid-based compounds to empower safe RNA drug delivery to Lungs Kumar Jeetendra | July 30, 2021 Japan’s Hokkaido University researchers created and tested a collection of lipid-based compounds in order to deliver RNA drugs safely and effectively to the lungs. The findings were published in Materials Horizons. The COVID-19 pandemic response made it all more familiar with RNA vaccines. These vaccines carry genetic code into the cells, which triggers the production …
Israel to offer third COVID booster shot to older residents Kumar Jeetendra | July 30, 2021 Israels prime minister on Thursday announced that the country would offer a coronavirus booster to people over 60 who have already been vaccinated. The announcement by Naftali Bennett makes Israel the first country to offer a third dose of the Pfizer/BioNtech vaccine to its citizens on a wide scale The decision came at a time …
AstraZeneca to look for US approval of Coronavirus immunization in second half Kumar Jeetendra | July 29, 2021 AstraZeneca said on Thursday that it intends to seek US authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application. The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million …
WHO has started audit process for emergency use listing of Bharat Biotech’s Covaxin: Govt Kumar Jeetendra | July 28, 2021 All documents required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the review process by the agency has commenced, Minister of State for Health Bharati Pravin Pawar told Rajya Sabha on Tuesday. Responding to a question on whether it has come …
Biosimilar Products for Research Use Kumar Jeetendra | July 27, 2021 AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics. Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs …
Brazil scraps Covaxin’s EUA application after Bharat Biotech ends agreement with accomplices Kumar Jeetendra | July 27, 2021 After suspending the proposed clinical trials of Bharat Bioetchs COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation request made by the Indian company for the jab. The Brazilian health regulator’s decisioncomesafter the vaccine maker informed the South American country about thetermination of its pact with its partners in that country. According to …
How the Delta variant overturns suppositions about the Covid Kumar Jeetendra | July 26, 2021 The Delta variant is the fastest, fittest and most formidable version of the coronavirus that causes COVID-19 the world has encountered, and it is upending assumptions about the disease even as nations loosen restrictions and open their economies, according to virologists and epidemiologists. Vaccine protection remains very strong against severe infections and hospitalizations caused by …
